Respiratory Care Devices Market Forecasts to 2032 - Global Analysis By Device Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices and Consumables & Accessories), Patient Type, Disease Type, Technology, End User, and By Geography

According to Stratistics MRC, the Global Respiratory Care Devices Market is accounted for $24.0 billion in 2025 and is expected to reach $42.0 billion by 2032 growing at a CAGR of 8.3% during the forecast period. Respiratory care devices are medical instruments designed to assist with breathing by supporting or enhancing respiratory function. They are used to treat individuals with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Devices in this category include oxygen concentrators, ventilators, nebulizers, CPAP machines, and spirometers. These tools facilitate airflow, deliver medication, or monitor lung performance, playing a crucial role in maintaining proper oxygen levels and overall pulmonary health.

According to the American Lung Association, which published an article in February 2023, there are more than 34 million Americans suffering from chronic lung diseases, including COPD, asthma, chronic bronchitis, and emphysema.

Market Dynamics:

Driver:

Rising prevalence of chronic respiratory diseases

The increasing global burden of chronic respiratory conditions, such as asthma, COPD, and sleep apnea, is a primary growth driver. Factors including aging populations, smoking habits, air pollution, and occupational hazards are contributing to rising incidence rates. Healthcare systems worldwide are under pressure to provide early diagnosis and efficient treatment, spurring demand for respiratory care devices. Enhanced public awareness and government screening initiatives are further catalyzing market adoption. This rising health concern is creating sustainable momentum for respiratory technology innovation.

Restraint:

High cost of advanced respiratory devices

Despite growing demand, the high cost of modern respiratory care devices-such as non-invasive ventilators, CPAP machines, and oxygen concentrators-poses a barrier to widespread adoption, especially in low- and middle-income countries. Many healthcare institutions struggle with budget constraints, limiting their ability to upgrade to advanced technologies. Moreover, patients in developing economies face affordability issues, restricting home-based usage. Insurance reimbursement gaps and out-of-pocket expenditures further aggravate this restraint, slowing down penetration in both public and private healthcare sectors.

Opportunity:

Technological advancements in portable and smart devices

The market is experiencing a significant opportunity due to the rapid development of portable and connected respiratory care devices. Smart inhalers, wireless nebulizers, and app-integrated oxygen therapy systems offer real-time monitoring and improved adherence. These innovations are especially beneficial in home healthcare and remote patient management. The integration of AI and IoT into respiratory devices is transforming disease management, allowing predictive diagnostics and proactive care. This technological shift is expected to unlock new revenue streams for manufacturers.

Threat:

Stringent regulatory approval processes

The market faces threats from rigorous regulatory standards and prolonged approval timelines. Obtaining FDA or CE certifications involves complex clinical trials, documentation, and compliance audits. Delays in market entry can increase R&D expenses and discourage smaller players from innovating. Furthermore, frequent changes in compliance frameworks can disrupt go-to-market strategies. Manufacturers must navigate regional differences in safety, efficacy, and quality control requirements, which can delay product launches and restrict international scalability of respiratory care solutions.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the respiratory care devices market. While it created an unprecedented demand spike for ventilators, oxygen therapy devices, and monitoring systems during 2020-2021, it also exposed supply chain vulnerabilities and triggered product shortages. Post-pandemic, healthcare facilities have prioritized respiratory readiness, boosting long-term investments in critical care infrastructure. The pandemic also accelerated the adoption of home-based respiratory care, telemonitoring tools, and portable devices, fundamentally reshaping care delivery models across both developed and developing regions.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to account for the largest market share during the forecast period propelled by, growing usage in treating chronic respiratory ailments like COPD, asthma, and sleep apnea. Increased demand for ventilators, CPAP devices, and nebulizers across both hospitals and home settings is boosting this segment. Technological innovation in non-invasive and portable therapeutic solutions is further enhancing adoption. Rising healthcare investments and patient preference for home care are reinforcing segment dominance across global markets.

The chronic obstructive pulmonary disease (COPD) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the chronic obstructive pulmonary disease (COPD) segment is predicted to witness the highest growth rate, influenced by the increasing prevalence of the disease and heightened awareness of its management. Factors such as rising air pollution, tobacco use, and aging populations are driving diagnosis rates. The need for early intervention, combined with expanding availability of COPD-specific devices like inhalers and oxygen concentrators, is fueling market expansion. Continuous innovation and digital integration in COPD monitoring are expected to sustain this rapid growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by, fueled by rapid urbanization, increasing air pollution, and a rising geriatric population. Countries such as China, India, and Japan are experiencing growing rates of respiratory diseases due to environmental and lifestyle factors. Government health reforms and expanding healthcare access in rural regions are also contributing to device uptake. Moreover, growing medical tourism and domestic manufacturing capacities make Asia Pacific a strategic market hub.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, technological innovation, robust healthcare infrastructure, and high patient awareness. The region benefits from early adoption of advanced respiratory therapies, strong insurance coverage, and active regulatory frameworks that support innovation. The U.S. and Canada are also experiencing rising prevalence of chronic respiratory conditions due to aging populations and lifestyle factors. The increasing shift toward home healthcare and smart monitoring tools further accelerates regional growth.

Key players in the market

Some of the key players in Respiratory Care Devices Market include Koninklijke Philips N.V., Medtronic, ResMed, Masimo, Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, Getinge, Nihon Kohden Corporation, GE Healthcare, Vyaire Medical, Inc., Baxter International, Inc., AdaptHealth, LLC, Teleflex Incorporated, Air Liquide, Invacare Corporation, ICU Medical, Hamilton Medical AG, Apex Medical Corp, Medline Industries, LP, and HUM Society for Homecare.

Key Developments:

In July 2025, ResMed introduced its first AI-powered sleep therapy platform that continuously adapts airflow based on patient breathing patterns, marking a step forward in personalized respiratory care for sleep apnea.

In June 2025, Dragerwerk AG & Co. KGaA enhanced its ventilator line by integrating advanced aerosol therapy modules, targeting improved respiratory outcomes in pediatric and neonatal intensive care units.

In April 2025, Philips expanded its homecare respiratory portfolio with a compact portable oxygen concentrator built for high-altitude environments, addressing oxygen therapy needs in under-served mountainous regions.

Device Types Covered:

• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables & Accessories

Patient Types Covered:

• Pediatric
• Adult
• Geriatric

Disease Types Covered:

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Sleep Apnea
• Infectious Disease
• Other Disease Types

Technologies Covered:

• Mechanical Respiratory Devices
• Digital & Smart Respiratory Monitoring Solutions
• Automated/AI-based Ventilatory Devices

End Users Covered:

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Laboratories
• Rehabilitation Centers

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances